Arkolith/Insider Trading/LIXT/Form 4

van der Baan Bastiaan Jeroen

President and CEO, DirectorLIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT) · full profile →Form 4 · filed Oct 5, 2023
Net Buying
Open-Market Buys
$28K
Open-Market Sells
$0
Net Open-Market Flow
$28K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 3, 2023Buy(P)10K$2.80$28K11K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-23-036422) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML